Jim Cramer Recently Discussed These 17 Stocks And Chinese Hackers
Jim Cramer's appearance on Squawk on the Street aired on January 17th covered a wide variety of topics.
Novo Nordisk A S (NVO)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Franchise Capital Simon Wang | 0 | $0 | -100% | 0% |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,527,772 | $2,330,498,036 | 1.73% | |
| 2. | 12,975,409 | $1,342,306,092 | 0.13% | |
| 3. | 12,663,225 | $1,310,010,512 | 0.1% | |
| 4. | 10,614,811 | $1,098,102,521 | 0.09% | |
| 5. | 8,631,264 | $892,904,261 | 18.17% |
News See All
Why NVO and LLY Are Dropping Today
Novo's Ozempic and Wegovy drugs have been selected for potential Medicare price negotiations, the Center for Medicare and Medicaid Services disclosed today.
Jim Cramer Discussed These 21 Stocks As Bond Yields Soared
In a recent episode of CNBC's Squawk On The Street, Jim Cramer started out by commenting on quantum computing stocks.
Does Novo Nordisk A/S (NVO) Have an Attractive Valuation?
ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S (NYSE:NVO) on Kontra Investments’ Substack by Kontra. In this article, we will summarize the bulls’ thesis on NVO.
13 Best Pharma Dividend Stocks To Buy In 2024
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions.
Here’s Why Novo Nordisk A/S (NVO) Slid in Q3
Loomis Sayles, an investment management company, released its “International Growth Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here.
Jim Cramer Discusses 17 Stocks And Blasts Zero Day Options
In his second appearance on Squawk on the Street after the Fed's interest rate cut, Jim Cramer had a lot to say about the Fed's decision and the Personal Consumption Expenditure (PCE) data release.
Why Novo Nordisk (NVO) Is Plummeting Today
Specifically, the weight of patients who received Novo's anti-obesity drug, CagriSema, declined by an average of 20.4% in 68 weeks, versus the 25% average weight loss that Novo had expected the treatment...
Novo Nordisk A/S (NVO) Fell as its Weight Loss Drug Faced Supply Constraints
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity” third quarter 2024, investor letter. A copy of the letter can be downloaded here.
Billionaire Hedge Funds
